FR2596771B1 - Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus - Google Patents

Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus

Info

Publication number
FR2596771B1
FR2596771B1 FR8605043A FR8605043A FR2596771B1 FR 2596771 B1 FR2596771 B1 FR 2596771B1 FR 8605043 A FR8605043 A FR 8605043A FR 8605043 A FR8605043 A FR 8605043A FR 2596771 B1 FR2596771 B1 FR 2596771B1
Authority
FR
France
Prior art keywords
glycoprotein
vector
vaccine
cell culture
recombinant dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8605043A
Other languages
English (en)
Other versions
FR2596771A1 (fr
Inventor
Marie-Paule Kieny
Guy Rautmann
Jean-Pierre Lecocq
Simon Wain Hobson
Marc Girard
Luc Montagnier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Priority to FR8605043A priority Critical patent/FR2596771B1/fr
Priority to FR8615106A priority patent/FR2606029B2/fr
Priority to DE3789400T priority patent/DE3789400T2/de
Priority to PT84640A priority patent/PT84640B/pt
Priority to ES87400790T priority patent/ES2052589T3/es
Priority to EP87400790A priority patent/EP0245136B1/fr
Priority to PCT/FR1987/000116 priority patent/WO1987006260A1/fr
Priority to JP62502264A priority patent/JP2719917B2/ja
Priority to CA000534170A priority patent/CA1341353C/fr
Priority to AT87400790T priority patent/ATE103328T1/de
Priority to AU72349/87A priority patent/AU604696B2/en
Publication of FR2596771A1 publication Critical patent/FR2596771A1/fr
Priority to DK198706417A priority patent/DK175613B1/da
Priority to KR87701159A priority patent/KR960001819B1/ko
Application granted granted Critical
Publication of FR2596771B1 publication Critical patent/FR2596771B1/fr
Priority to US07/765,413 priority patent/US5169763A/en
Priority to US08/442,995 priority patent/US5672689A/en
Priority to US08/481,622 priority patent/US5795577A/en
Priority to JP7277533A priority patent/JP2743164B2/ja
Priority to JP9131138A priority patent/JPH1059868A/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR8605043A 1986-04-08 1986-04-08 Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus Expired FR2596771B1 (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FR8605043A FR2596771B1 (fr) 1986-04-08 1986-04-08 Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
FR8615106A FR2606029B2 (fr) 1986-04-08 1986-10-29 Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
AT87400790T ATE103328T1 (de) 1986-04-08 1987-04-08 Fuer ein glykoprotein des aids-virus kodierende virus-vektoren, vakzin und antikoerper.
ES87400790T ES2052589T3 (es) 1986-04-08 1987-04-08 Vector viral, codificante para una glicoproteina del virus responsable del sida, vacuna y anticuerpo.
EP87400790A EP0245136B1 (fr) 1986-04-08 1987-04-08 Vecteur viral, codant pour une glycoprotéine du virus responsable du SIDA, vaccin et anticorps
PCT/FR1987/000116 WO1987006260A1 (fr) 1986-04-08 1987-04-08 Vecteur viral, codant pour une glycoproteine du virus responsable du s.i.d.a., vaccin et anticorps
JP62502264A JP2719917B2 (ja) 1986-04-08 1987-04-08 Ａｉｄｓの原因ウィルスの糖蛋白質、該糖蛋白質の製造方法及びワクチン
CA000534170A CA1341353C (fr) 1986-04-08 1987-04-08 Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
DE3789400T DE3789400T2 (de) 1986-04-08 1987-04-08 Für ein Glykoprotein des AIDS-Virus kodierende Virus-Vektoren, Vakzin und Antikörper.
AU72349/87A AU604696B2 (en) 1986-04-08 1987-04-08 Viral vector coding for a glycoprotein of the virus responsible for a.i.d.s., vaccine and antibody
PT84640A PT84640B (pt) 1986-04-08 1987-04-08 Vector viral que contem um gene que codifica para uma das glicoproteinas (gp) do involucro do virus responsavel pela s.i.d.a. e anticorpos contra essas glicoproteinas
DK198706417A DK175613B1 (da) 1986-04-08 1987-12-07 Virusvektor, der koder for et glycoprotein fra det virus, der er ansvarligt for AIDS, vaccine, der omfatter virusvektoren eller glycoproteinet, samt antistof mod glycoproteinet
KR87701159A KR960001819B1 (en) 1986-04-08 1987-12-08 Viral vector coding for a glycoprotein of the virus responsible
US07/765,413 US5169763A (en) 1986-04-08 1991-09-24 Viral vector coding glycoprotein of HIV-1
US08/442,995 US5672689A (en) 1986-04-08 1995-05-17 Non-cleavable GP160 glycoproteins of HIV
US08/481,622 US5795577A (en) 1986-04-08 1995-06-07 Viral vector coding for a glycoprotein of the virus responsible for A.I.D.S.
JP7277533A JP2743164B2 (ja) 1986-04-08 1995-10-25 Ａｉｄｓの原因ウィルスの糖蛋白質をコードするウィルスベクター及び組換えｄｎａ、該ベクターにより感染された細胞培養物、並びに抗体
JP9131138A JPH1059868A (ja) 1986-04-08 1997-05-21 Ａｉｄｓの原因ウィルスの糖蛋白質からなるワクチン

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8605043A FR2596771B1 (fr) 1986-04-08 1986-04-08 Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus

Publications (2)

Publication Number Publication Date
FR2596771A1 FR2596771A1 (fr) 1987-10-09
FR2596771B1 true FR2596771B1 (fr) 1988-10-21

Family

ID=9334043

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8605043A Expired FR2596771B1 (fr) 1986-04-08 1986-04-08 Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus

Country Status (1)

Country Link
FR (1) FR2596771B1 (fr)

Also Published As

Publication number Publication date
FR2596771A1 (fr) 1987-10-09

Similar Documents

Publication Publication Date Title
Yang et al. Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins
FR2606029B2 (fr) Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
EP0265785A3 (fr) Polypeptides dérivés du gène d'enveloppe du virus d'immuno-dépression acquise, dans des cellules d'insectes infectées par un baculovirus recombinant
NO975434L (no) Fremgangsmåte for fremstilling av influensa hemagglutinin multivalente vaksiner
DK605987D0 (da) Bestemte dna-sekvenser afledt af et papillomavirus-genom, deres anvendelse til in vitro diagnoseformaal og fremstilling af antigeniske praeparater
DK33190A (da) Hiv-3 retrovirus og anvendelse heraf
KR910012233A (ko) 칠면조의 재조합 포진바이러스와 그것에서 유도한 생존상태의 벡터 백신류
TNSN88004A1 (fr) Antigenes de surface du virus de l'hepatite b et antigenes hybrides les contenant
JP2001527029A5 (fr)
ES8801372A1 (es) Un metodo para preparar una vacuna contra el virus de la influenza equina.
EP0272858A3 (fr) Protéines recombinantes d'enveloppe du HIV, produites dans des cellules d'insectes
ES8706208A1 (es) Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia
KR970705408A (ko) 헤모필루스 부착 및 침투 단백질(haemophilus adherence and penetration proteins)
DK637988A (da) Rekombinante polypeptider
FR2600079B1 (fr) Vecteur viral et adn recombinant codant pour la proteine f du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la proteine, proteine obtenue, vaccin et anticorps obtenus
YOURNO et al. Nucleotide sequence analysis of the env gene of a new Zairian isolate of HIV-1
FR2596771B1 (fr) Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
EP0315242A3 (fr) Procédé de purification des antigènes de l'hépatite obtenus par voie recombinante
Mahnke et al. Specific enzyme-linked immunosorbent assay for the detection of antibodies to the human spumavirus
DK498387A (da) Virus-dna-sekvens
FR2620030B1 (fr) Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus
FR2607518B1 (fr) Vecteur viral et adn recombinant codant pour la proteine p25 du virus agent causal du s.i.d.a., culture cellulaire infectee, proteine obtenue, vaccin et anticorps obtenus
DE3853693D1 (de) DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
NZ222766A (en) Aids virus antigens: env/gag polypeptides: production by genetic engineering techniques: vaccines, and methods of diagnostic testing
FR2617715B1 (fr) Vecteur viral et adn recombinant codant pour une ou des proteines de surface (ha et/ou f) d'un morbillivirus, culture cellulaire infectee, proteines obtenues, vaccin et anticorps obtenus

Legal Events

Date Code Title Description
ER Errata listed in the french official journal (bopi)

Free format text: BO 04/87 PAGE 48:ANNULATION

CD Change of name or company name
CL Concession to grant licences
ST Notification of lapse